Eisai Co., Ltd. (TYO: 4523)
Japan
· Delayed Price · Currency is JPY
4,316.00
-23.00 (-0.53%)
Dec 20, 2024, 3:45 PM JST
Eisai Employees
Eisai had 11,067 employees as of March 31, 2024. The number of employees decreased by 9 or -0.08% compared to the previous year.
Employees
11,067
Change (1Y)
-9
Growth (1Y)
-0.08%
Revenue / Employee
68.06M JPY
Profits / Employee
3.70M JPY
Market Cap
1,216.63B
Employees Chart
Employees History
Eisai News
- 10 days ago - Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia - Benzinga
- 16 days ago - Biogen Inc (BIIB) and Eisai's Alzheimer's Drug LEQEMBI Approved in Mexico - GuruFocus
- 4 weeks ago - Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026 - Benzinga
- 5 weeks ago - Eisai wins orphan drug status for Lenvima for esophageal cancer - Seeking Alpha
- 5 weeks ago - Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease - PRNewsWire
- 5 weeks ago - Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug - MarketWatch
- 5 weeks ago - Biogen gains as Eisai wins EU nod for Alzheimer’s drug - Seeking Alpha
- 5 weeks ago - EU drugs regulator recommends Alzheimer's drug from Eisai-Biogen - Reuters